ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals Ownership Summary
ACADIA Pharmaceuticals is owned by 97.68% institutional investors, 0.57% insiders, and 1.76% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.83% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.56% of its assets in ACADIA Pharmaceuticals shares.
ACAD Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | ACADIA Pharmaceuticals | 97.68% | 0.57% | 1.76% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 42.88M | 25.83% | $786.81M |
Vanguard group | 13.95M | 8.40% | $255.94M |
Blackrock funding, inc. /de | 12.73M | 7.67% | $233.59M |
Blackrock | 12.06M | 7.32% | $196.01M |
Rtw investments, lp | 8.71M | 5.25% | $159.75M |
State street | 4.52M | 2.72% | $82.97M |
D. e. shaw | 3.24M | 1.95% | $59.48M |
Goldman sachs group | 2.88M | 1.74% | $52.86M |
Geode capital management | 2.88M | 1.73% | $52.81M |
Palo alto investors lp | 2.75M | 1.66% | $50.44M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Baker bros. advisors lp | 42.88M | 8.40% | $786.81M |
Palo alto investors lp | 2.75M | 7.82% | $50.44M |
Birchview capital, lp | 338.40K | 5.06% | $6.21M |
Cannon global investment management | 117.99K | 4.70% | $2.17M |
Stonepine capital management | 220.00K | 3.26% | $4.04M |
Rtw investments, lp | 8.71M | 2.42% | $159.75M |
Tang capital management | 1.50M | 1.82% | $27.52M |
Nan fung group | 102.98K | 1.62% | $1.89M |
Jgp global gestao de recursos ltda. | 34.62K | 1.45% | $635.28M |
Cm management | 70.00K | 1.15% | $1.28M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | 2.23M | 0.09% | 2.23M |
Citigroup | 1.67M | 0.02% | 1.55M |
Norges bank | 1.39M | 0.00% | 1.39M |
Jacobs levy equity management | 1.36M | 0.09% | 1.36M |
Goldman sachs group | 2.88M | 0.01% | 1.12M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 8.71M | 2.42% | -5.00M |
State street | 4.52M | 0.00% | -1.45M |
Ecor1 capital | - | - | -1.35M |
Millennium management | 1.12M | 0.01% | -934.76K |
Finepoint capital lp | - | - | -905.38K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 1.39M | 0.00% | 1.39M | $25.55M |
Great lakes advisors | 540.01K | 0.08% | 540.01K | $9.91M |
Burney co/ | 378.90K | 0.25% | 378.90K | $6.95M |
Neo ivy capital management | 203.05K | 0.65% | 203.05K | $3.30M |
Cannon global investment management | 117.99K | 4.70% | 117.99K | $2.17M |
Sold Out
Holder | Change |
---|---|
Concord wealth partners | -10.00 |
Bokf, na | -16.00 |
Capital performance advisors llp | -25.00 |
Global retirement partners | -40.00 |
Huntington national bank | -50.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 294 | 9.70% | 162,117,227 | 4.78% | 97 | 1.12% | 171 | 34.65% | 74 | -7.50% |
Sep 30, 2024 | 266 | -3.97% | 154,699,805 | -3.89% | 93 | 0.99% | 127 | -15.89% | 80 | 1.27% |
Jun 30, 2024 | 275 | -4.51% | 160,951,158 | 0.75% | 97 | 1.04% | 150 | -3.23% | 78 | 5.41% |
Mar 31, 2024 | 288 | -2.04% | 159,752,773 | 0.26% | 96 | 1.02% | 155 | -4.32% | 74 | 1.37% |
Dec 31, 2023 | 294 | 11.36% | 159,346,491 | 2.98% | 97 | 1.10% | 162 | 23.66% | 73 | -1.35% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 7.61M | 4.56% | 4.76K |
Vanguard Total Stock Mkt Idx Inv | 3.94M | 2.36% | 15.85K |
Vanguard US Total Market Shares ETF | 3.89M | 2.33% | 4.42K |
iShares Russell 2000 ETF | 3.15M | 1.89% | -27.28K |
Vanguard Small Cap Index | 3.12M | 1.87% | -66.65K |
SPDR® S&P Biotech ETF | 2.45M | 1.47% | -26.30K |
First Trust NYSE Arca Biotech ETF | 2.17M | 1.30% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 1.91M | 1.15% | 49.18K |
Vanguard Small Cap Growth Index Inv | 1.75M | 1.05% | -34.36K |
Fidelity Small Cap Index | 1.18M | 0.71% | -22.14K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 08, 2025 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $40.13K |
Apr 08, 2025 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Sell | $15.23K |
Mar 26, 2025 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Sell | $18.67K |
Mar 26, 2025 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $54.07K |
Mar 05, 2025 | GAROFALO ELIZABETH A. | - | Sell | $89.67K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 2 |
2025 Q1 | - | 5 |
2024 Q4 | - | 3 |
2024 Q3 | - | 3 |
2024 Q2 | - | 11 |
ACAD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools